International Journal of Drug Policy
Volume 13, Issue 2 , Pages 95-102 , June 2002

Needle exchange and difficulty with needle access during an ongoing HIV epidemic

  • Evan Wood

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver, BC, Canada V6T 1Z3
    • ,
  • Mark W. Tyndall

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver, BC, Canada V6T 1Z3
    • ,
  • Patricia M. Spittal

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver, BC, Canada V6T 1Z3
    • ,
  • Kathy Li

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • ,
  • Robert S. Hogg

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver, BC, Canada V6T 1Z3
    • ,
  • Michael V. O'Shaughnessy

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Pathology and Laboratory Medicine; University of British Columbia, Vancouver, BC, Canada
    • ,
  • Martin T. Schechter

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Ave., Vancouver, BC, Canada V6T 1Z3
    • Corresponding Author InformationCorresponding author. Tel.: +1-604-822-3081; fax: +1-604-806-9044

References 

  1. American Journal of Public Health (2000). Discussion, American Journal of Public Health 90, 1385–1396.
  2. Bellm J. Needle-exchange programmes are not the answer. Lancet. 1999;353:1657–1661 letter; comment
  3. Bennett SS. Needle-exchange programmes in the USA. Lancet. 1998;351:839; letter; comment see comments
  4. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605–611
  5. Case P, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 1998;18(Suppl. 1):S71–S75
  6. City of Vancouver. (2000). Needle Exchange Review. Summary of Findings to Date.
  7. Coffin P. Syringe availability as HIV prevention: a review of modalities. Journal of Urban Health. 2000;77:306–310
  8. Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998–1999. Journal of Acquired Immune Deficiency Syndromes. 2001;27:183–192
  9. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology. 1996;143:725–732
  10. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991
  11. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomized trial. Lancet. 1999;353:1657–1661
  12. Dolan KA. Can hepatitis C transmission be reduced in australian prisons. Medical Journal of Australia. 2001;174:378–379
  13. Health Canada (1998). Consortium to Characterize Injection Drug Users in Canada Montreal, Toronto, and Vancouver.
  14. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment. Journal of Substance Abuse Treatment. 1998;15:183–191
  15. Junge B, Valente T, Latkin C, Riley E, Vlahov D. Syringe exchange not associated with social network formation: results from Baltimore. AIDS. 2000;14:423–426
  16. Kent H. Should prisons ease drug prohibition to help reduce disease spread. Canadian Medical Association Journal. 1996;155:1489–1491
  17. Lurie, P., Reingold, A., & Bowser, B. E. A. (1993). The Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions, and Recommendations. Berkeley/San Francisco: School of Public Health, University of California, San Francisco, October 1993.
  18. Miller CL, Tyndall MW, Li K, Spittal PM, Schechter MT. Needle exchange source and risk taking behaviors among injection drug users. Canadian Journal of Infectious Diseases. 2001;12:70B
  19. Myers T, Cockerill R, Worthington C, Millson M, Rankin J. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada. AIDS Care. 1998;10:689–700
  20. Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France. American Journal of Public Health. 1999;89:1852–1854
  21. Office of National Drug Control Policy (1998). Executive Office of the President, Washington, DC. Task Force Report on a Site Visit to Vancouver.
  22. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, et al. The incidence of hepatitis C virus infection among injecting drug users during an outbreak of HIV infection. Canadian Medical Association Journal 2. 2000;165(7):889–895
  23. Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. American Journal of Public Health. 2001;91:699–700
  24. Riley ED, Safaeian M, Strathdee SA, Marx MA, Huettner S, Beilenson P, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. Journal of Acquired Immune Deficiency Syndromes. 2000;24:57–61
  25. Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999;11:437–442
  26. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. Canadian Medical Association Journal. 1994;151:781–787
  27. Royal Canadian Mounted Police Criminal Intelligence Directorate (2000). Drug situation in Canada, 1999.
  28. Schechter M, Currie S, Strathdee SA, O'Shaughnessy MV, Patrick DM, Rekart ML, et al. Maximizing needle exchange coverage among injection drug users (IDUs): do mobile programs attract those at highest risk. International Conference on AIDS. 1998;12:631; abstract no. 33196
  29. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS. 1999;13:F45–F51
  30. Singer M, Stopka T, Siano C, Springer K, Barton G, Khoshnood K, et al. The social geography of AIDS and hepatitis risk: qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health. 2000;90:1049–1056
  31. Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92:1339–1347
  32. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–65
  33. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macalino G, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health. 1999;76:448–460
  34. Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, Cameron S, et al  Outbreak of HIV infection in a Scottish prison. British Medical Journal. 1995;310:289–292
  35. Tyndall MW, Spittal PM, Laliberte N, Li K, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as a primary risk factor of HIV seroconversion among polydrug users in Vancouver. Canadian Journal of Infectious Diseases. 2001;12:70B
  36. Wood, E., Tyndall, M. W., Spittal, P., Li, K., R. S., H., O'Shaughnessy, M., & Schechter, M. T. (2001a). Predictors of Persistent High-Risk Syringe Sharing During an Ongoing HIV Epidemic. Canadian Journal of Infectious Diseases 12 (Suppl. B).
  37. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help. Canadian Medical Association Journal. 2001;165:405–410

PII: S0955-3959(02)00008-7

International Journal of Drug Policy
Volume 13, Issue 2 , Pages 95-102 , June 2002

Article Tools

* Image Usage & Resolution